1,534
Views
45
CrossRef citations to date
0
Altmetric
Research Article

Microextraction by packed sorbent and HPLC–PDA quantification of multiple anti-inflammatory drugs and fluoroquinolones in human plasma and urine

, , , , , , , , , & show all
Pages 110-116 | Received 15 Jun 2016, Accepted 28 Jun 2016, Published online: 22 Jul 2016

Figures & data

Figure 1. Chemical structures of NSAIDs, FLQs and internal standards.

Figure 1. Chemical structures of NSAIDs, FLQs and internal standards.

Table 1. Chromatographic gradient elution.

Figure 2. Chromatograms of different samples after MEPS extraction. Top side, plasma MEPS–HPLC–PDA chromatogram: (a) double blank, (b) blank spiked with internal standards and (c) blank spiked with internal standards and 1 μg/mL of all analytes. Bottom side, urine MEPS–HPLC–PDA chromatogram: (a) double blank, (b) blank spiked with internal standards and (c) blank spiked with internal standards and 1 μg/mL of all analytes. About 20 μL of samples injected at 285 nm. Key legend: levofloxacin (1), ciprofloxacin (2), enrofloxacin (IS1), ulifloxacin (3), sarafloxacin (IS2), moxifloxacin (4), furprofen (5), indoprofen (6), ketoprofen (7), fenbufen (8), flurbiprofen (9), indomethacin (10) and ibuprofen (11).

Figure 2. Chromatograms of different samples after MEPS extraction. Top side, plasma MEPS–HPLC–PDA chromatogram: (a) double blank, (b) blank spiked with internal standards and (c) blank spiked with internal standards and 1 μg/mL of all analytes. Bottom side, urine MEPS–HPLC–PDA chromatogram: (a) double blank, (b) blank spiked with internal standards and (c) blank spiked with internal standards and 1 μg/mL of all analytes. About 20 μL of samples injected at 285 nm. Key legend: levofloxacin (1), ciprofloxacin (2), enrofloxacin (IS1), ulifloxacin (3), sarafloxacin (IS2), moxifloxacin (4), furprofen (5), indoprofen (6), ketoprofen (7), fenbufen (8), flurbiprofen (9), indomethacin (10) and ibuprofen (11).

Table 2. Quantitative analysis of NSAIDs contained in commercial medications after the oral administration in human volunteers.

Supplemental material

IENZ_1209496_Supplementary_Material.pdf

Download PDF (680.7 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.